CRT slides: Data and safety monitoring boards—friend or foe to CV trials?

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
 - Business

WASHINGTON, D.C.—Independent data and safety monitoring boards are a necessary component of any cardiovascular trial involving human participants, but they have received a great deal of scrutiny due to some controversies about decision-making. Ajay J. Kirtane, MD, explained the legal role and responsibilities of these powerful oversight arms of trials.  

About the presenter:

Kirtane is the chief academic officer and director of the interventional cardiology fellowship program at Columbia University Medical Center/NewYork-Presbyterian Hospital in New York City.